product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Musashi Antibody
catalog :
2154S
quantity :
100 ul
price :
235 USD
clonality :
polyclonal
host :
rabbit
reactivity :
human, mouse, rat
application :
western blot, immunohistochemistry, immunocytochemistry, immunohistochemistry - frozen section
citations: 2
Published Application/Species/DilutionReference
Longshore S, Nair R, Perrone E, Erwin C, Guo J, Warner B. p21(waf1/cip1) deficiency does not perturb the intestinal crypt stem cell population after massive small bowel resection. J Pediatr Surg. 2009;44:1065-71; discussion 1071 pubmed publisher
Shiras A, Chettiar S, Shepal V, Rajendran G, Prasad G, Shastry P. Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma. Stem Cells. 2007;25:1478-89 pubmed
product information
SKU :
2154S
Product-Name :
Musashi Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, (Z)
Applications :
Immunofluorescence (Frozen)
Product-Category :
Neuroscience
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
35
Host :
Rabbit
Target :
Musashi
Primary-Protein :
MSI1
Alt-Names :
MSI1,MSI1H,Musashi-1,RNA-binding protein Musashi homolog 1,musashi 1,musashi homolog 1 (Drosophila)
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.